Medical/Pharmaceuticals

FDA Clears Numares Health Cardiovascular Diagnostic Test and Core Technology Platform

THE WOODLANDS, Texas and REGENSBURG, Germany, Aug. 1, 2023 /PRNewswire/ -- The US Food and Drug Administration has cleared a Numares Health test, theAXINON®  LDL-p Test System, as a new tool physicians can use to measure lipoproteins for patients at risk for cardiovascular disease. Currently, Numa...

2023-08-01 01:11 1603

Transforming Personal Trials into Triumphs: Project M.A.T.T.Y. Pioneers AI-Driven Autism and ADHD Support

SINGAPORE, Aug. 1, 2023 /PRNewswire/ -- Project M.A.T.T.Y., the remarkable initiative born out of personal experiences with Autism and ADHD, represents a monumental leap forward in supporting children and families managing these conditions. Co-founded by Dr.Pamela Lim, Nora Lam, and Khong Loon, t...

2023-08-01 00:15 1430

Transcenta Anti-sclerostin Monoclonal Antibody TST002 (Blosozumab) Received Approval from China CDE to Initiate Phase II Clinical Trial in Patients with Reduced Bone Mineral Density

SUZHOU, China, July 31, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that it has receiv...

2023-07-31 08:10 1475

Daewoong Pharmaceutical submits a new drug application for Fexuprazan in China challenging the world's largest market for anti-ulcer drugs

– Daewoong Pharmaceutical, "Expecting the smooth approval with the successful phase 3 clinical trial inChina aiming to reach 100 countries by 2027" SEOUL, South Korea, July 31, 2023 /PRNewswire/ -- Daewoong Pharmaceutical's domestically produced drug no. 34 Fexuprazan, a newly developed one for t...

2023-07-31 08:00 1773

Yodaplus: Shaping the Future of Industries with Powerful AI Integration

Leveraging artificial intelligence, Mumbai-based IT services firm Yodaplus is catalyzing industry transformations, from nutraceuticals to retail, by streamlining business operations and boosting decision-making capabilities. MUMBAI, India, July 31, 2023 /PRNewswire/ -- Yodaplus

2023-07-31 07:30 1563

Latest Updates of 7 Viva's Portfolio Companies

HONG KONG, July 28, 2023 /PRNewswire/ -- In the face of ever-changing circumstances, technological innovation remains the eternal driving force behind the long-term growth of biopharmaceutical companies. It continuously breathes life into these enterprises, enabling them to successfully transitio...

2023-07-28 19:31 5653

HANQUYOU Marks 3rd Anniversary with Brilliant Achievements

* HANQUYOU is the China-developed biosimilar with the most marketing approvals, covering 41 countries and regions * The launch of HANQUYOU kicks off the competition between Chinese pharmaceutical companies and the world's bio-pharmaceutical companies in biosimilar monoclonal antibodies * He...

2023-07-28 15:53 3198

Eeva Medical Aesthetic Clinic moves to brand new location at Raffles Place, launches fresh website

Ushering in a new era of growth, Eeva Aesthetics focuses all efforts on bringing game-changing technology to the medical aesthetic space, starting with expanding EMFACE inSingapore. SINGAPORE, July 28, 2023 /PRNewswire/ -- Eeva Medical Aesthetic Clinic launches their brand new space in the heart...

2023-07-28 13:13 2034

BPEA EQT to acquire a majority stake in Indira IVF - India's largest chain of fertility clinics

* BPEA EQT to acquire a majority stake in Indira IVF, the largest provider of fertility services inIndia and top five globally in terms of annual IVF cycles, having facilitated 125,000 successful pregnancies to date * India is one of the fastest growing markets globally for Assisted Reproduct...

2023-07-28 12:11 1703

GILEAD LAUNCHES GLOBAL ALL4LIVER GRANT PROGRAM TO HELP ACHIEVE THE WORLD HEALTH ORGANIZATION'S GOAL OF VIRAL HEPATITIS ELIMINATION BY 2030

– Gilead expands the ALL4LIVER Grant, Providing Grant Funding to Organizations inAfrica, South America, Asia and Oceania, Europe and North America –   – Themed 'Test. Link. Prioritize', the Grant Program will Target Projects Focusing on Viral Hepatitis Elimination by 2030 –  SINGAPORE, July 28, ...

2023-07-28 12:00 5086

Sirnaomics Appoints Dr. Francois Lebel as Senior Vice President for Preclinical and Clinical Development

HONG KONG, Germantown, Md. and SUZHOU, China, July 28, 2023 /PRNewswire/ --  Sirnaomics Ltd. (the "Company", Stock Code: 2257.HK, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, today announced tha...

2023-07-28 11:56 1988

61.6 percent of Young Thai Women Put off by Pap Smears: BGI Genomics Cervical Cancer Survey

* 61.6% of Thai women aged 21-25 years deterred by pap smears which is higher than the global average of 43.5% HONG KONG, July 28, 2023 /PRNewswire/ -- Only 28.5% of Thai women are diagnosed at stage I of cervical cancer when survival rates are highest, according to a study

2023-07-28 08:37 1408

Nutromics attracts world leaders in the emerging field of DNA-based sensing to join its Biosensor Advisory Board

MELBOURNE, Australia, July 28, 2023 /PRNewswire/ -- Nutromics has announced today that its lab-on-a-patch technology has attracted the support of multiple world-class experts from leading US and Australian institutions, who now comprise its Biosensor Advisory Board. Nutromics is a leader in conti...

2023-07-28 08:27 1685

TraceLink Accelerates DSCSA 2023 Customer Readiness, Supply Chain Digitalization, and Drug Shortage Predictability in Second Quarter of 2023

As the industry prepares for DSCSA 2023 regulations, 50% of the US MAH market is now EPCIS-enabled through the TraceLink B2N Integrate-Once network. This digital foundation is allowing them to enhance supply chain visibility, collaboration, and resilience. BOSTON, July 28, 2023 /PRNewswire/ -- T...

2023-07-28 05:48 1721

World Hepatitis Alliance raise awareness of viral hepatitis on World Hepatitis Day as research shows hepatitis B and C cause significantly higher cancer risk than smoking a daily pack of cigarettes

LONDON, July 28, 2023 /PRNewswire/ -- Today, World Hepatitis Day (WHD) launches with the call to action 'We're not waiting'. On WHD, the World Hepatitis Alliance (WHA) joins together with its global network of 323 members in over 100 countries to lead the campaign internationally to accelerate th...

2023-07-28 04:02 1817

NEC Thailand and Thammasat Thammarak Center to trial digital health platform

BANGKOK, July 27, 2023 /PRNewswire/ -- NEC Corporation (Thailand) Ltd. (NEC Thailand), has signed a Memorandum of Understanding (MoU) withThammasat University Hospital to collaborate on the development of a digital platform aimed at supporting the hospital's healthcare system.

2023-07-27 16:41 1986

Clarivate Enhances Patient Data Intelligence Solution with Addition of German Hospital Prescribing Insights

New data captures German prescribing insights providing researchers with aggregated, anonymised specialty prescribing habits across brands and diseases LONDON, July 27, 2023 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they ca...

2023-07-27 15:00 1515

Frost & Sullivan Awarded Duopharma Biotech with the 2022 Malaysian Company of the Year Award

Duopharma Biotech is the first pharmaceutical company to offer biosimilar products in the Malaysian market. SAN ANTONIO, July 27, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the Malaysian biosimilars industry and, based on its findings, recognizesDuopharma Biotech Berhad (Duopharma...

2023-07-27 14:00 1391

Acceptance Of Clinical Trial Application For The Recbio's Novel Adjuvanted Recombinant Shingles Vaccine REC610 In China And Overseas Clinical Trial Progress

TAIZHOU, China, July 27, 2023 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the"Board") is pleased to announce that the Group has recently received the notice of acceptance (acceptance number: CXSL2300518) issued by National Medical Products Administration ("NMPA"), pursuant to which the c...

2023-07-27 10:57 3855

Everest Medicines Announces Commercial Launch and First Prescription for XERAVA® in China

Everest transforms into a commercial-stage innovative biopharmaceutical company SHANGHAI, July 27, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicin...

2023-07-27 08:10 1811
1 ... 52535455565758 ... 383